These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23648925)

  • 1. Response.
    Whitlock R; Danter M
    Chest; 2013 May; 143(5):1514. PubMed ID: 23648925
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic and thrombolytic therapy for valvular disease: can this guideline apply to Chinese?
    Fu B; Chen H; Dong L
    Chest; 2013 May; 143(5):1513-1514. PubMed ID: 23648923
    [No Abstract]   [Full Text] [Related]  

  • 3. Executive summary: Prevention of thromboembolic events: the role of point of care management.
    J Heart Valve Dis; 2007 Mar; 16(2):184-6. PubMed ID: 17607861
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombotic therapy in atrial fibrillation].
    da Costa JT
    Acta Med Port; 1999; 12(7-11):245-54. PubMed ID: 10707462
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW
    Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Salem DN; Stein PD; Al-Ahmad A; Bussey HI; Horstkotte D; Miller N; Pauker SG
    Chest; 2004 Sep; 126(3 Suppl):457S-482S. PubMed ID: 15383481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The most recent recommendations for "deep blocks" and thromboprophylaxis: evidence not supporting a "thromboprophylaxis therapeutic window".
    Chelly JE
    Reg Anesth Pain Med; 2010; 35(4):402; author reply 402-3. PubMed ID: 20588153
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombotic therapy for coronary artery disease and valvular heart disease.
    Israel DH; Fuster V; Chesebro JH; Badimon L
    Baillieres Clin Haematol; 1990 Jul; 3(3):705-43. PubMed ID: 2271788
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protocols for the prevention and treatment of thromboembolic disease (III). Antithrombotic therapy in coronary disease. The Editorial Committee on Protocols (1)].
    Med Clin (Barc); 1994 Sep; 103(9):344-7. PubMed ID: 7967896
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
    Prisco D
    Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy in valvular heart disease.
    Salem DN; Levine HJ; Pauker SG; Eckman MH; Daudelin DH
    Chest; 1998 Nov; 114(5 Suppl):590S-601S. PubMed ID: 9822065
    [No Abstract]   [Full Text] [Related]  

  • 13. Is early antithrombotic therapy necessary in bioprosthetic valves?
    Mestres CA; Aramendi JI
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):724-5; author reply 725-6. PubMed ID: 20723739
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment alternatives in mechanical valve thrombosis].
    Duran NE; Biteker M; Ozkan M
    Turk Kardiyol Dern Ars; 2008 Sep; 36(6):420-5. PubMed ID: 19155650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracardiac thrombosis and consecutive thromboembolisms in patients with heart valve diseases: predisposition and concepts for prevention].
    Piper C; Horstkotte D
    Z Kardiol; 1998; 87 Suppl 4():1-6. PubMed ID: 9857461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of thrombosis in heart valve diseases].
    Meyer BJ; Beer JH
    Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy in pediatrics: time for higher levels of evidence.
    Faix RG
    J Pediatr; 2000 Apr; 136(4):425-6. PubMed ID: 10753235
    [No Abstract]   [Full Text] [Related]  

  • 18. [The current indications for antithrombotic treatment in valve disease].
    del Río del Busto A; Pardo Vigo A
    Rev Esp Cardiol; 1991 Mar; 44(3):190-202. PubMed ID: 2047549
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombolytic therapy.
    Schrier SL
    Ann Intern Med; 1980 Oct; 93(4):629-30. PubMed ID: 7436197
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombotic therapy for patients with valvular heart disease.
    Vahanian A
    Herz; 2008 Feb; 33(1):44-51. PubMed ID: 18273577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.